Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.24 EUR | -1.36% |
|
+1.55% | -0.66% |
06-25 | Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval | MT |
06-25 | Roche: approval of Ocrevus SC in Europe | CF |